2016年2月12日下午，复旦大学药学院院长在美国加州圣迭戈市会晤了多名在生物医药领域从事创业和投资活动的专业人士。他们是：美国Concortis Biotherapeutics公司总裁陈刚博士、 美国Sorrento Therapeutics公司（NASDAQ: SRNE）首席执行官季红俊博士、南京联宁生物制药有限公司首席执行官李辉博士、浙商银行上海分行信贷部主任沈珍飞女士和美国投资银行FBR & Co.专员蔡逸驰先生。大家认真讨论了在上海张江高科技园区投资建立抗体偶联技术中心的动议。
Professor Ming-Wei Wang meets a group of professionals in San Diego
In the afternoon of February 12, 2016, Professor Ming-Wei Wang, Dean, School of Pharmacy, Fudan University met with a group of professionals who are engaged in biopharmaceutical entrepreneur or investment activities, at San Diego, California, USA. They include: Dr. Gang Chen (President of Concortis Biotherapeutics, Inc., USA), Dr. Henry (Hongjun) Ji (CEO of Sorrento Therapeutics, Inc., USA; NASDAQ: SRNE), Dr. Hui Li (CEO of Levena Biopharma, Nanjing, China), Madam Zhenfei Shen (Head of Loan and Credit Department, Shanghai Branch, China Zheshang Bank) and Mr. Yichi Cai (Associate of investment bank FBR & Co.). They seriously discussed a proposition of investing and establishing an antibody conjugate technology center in Zhangjiang High-Tech Park, Shanghai.
